Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00288106 · ClinicalTrials.gov registry record
S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT
A clinical trial, sponsored by SWOG Cancer Research Network.
- Terminated
- Registry status
- 961
- Enrollment target
NCT00288106 is a clinical trial that was terminated before completion, run by SWOG Cancer Research Network. The registered enrollment target is 961 participants.
The verdict
NCT00288106 was terminated before completion, sponsored by SWOG Cancer Research Network.
- TERMINATED
- Registry status
- 961 participants
- Enrollment target
Study Summary
RATIONALE: Learning about the long-term effects of chemoprevention drugs, such as finasteride, in patients with prostate cancer may help doctors plan better treatment and follow-up care. PURPOSE: This clinical trial is following patients who were diagnosed with prostate cancer while undergoing treatment with either finasteride or a placebo on the Prostate Cancer Prevention Trial (PCPT).
Interventions
- OTHER Follow-up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 961 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00288106
The ClinicalTrials.gov registry entry for NCT00288106 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 961 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Follow-up is the first listed.
NCT00288106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00288106 about?
NCT00288106 is a clinical study titled "S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT". RATIONALE: Learning about the long-term effects of chemoprevention drugs, such as finasteride, in patients with prostate cancer may help doctors plan better treatment and follow-up care. PURPOSE: This clinical trial is following patients who were diagnosed with prostate cancer while undergoing trea...
What is the current status of trial NCT00288106?
This trial is currently terminated. The enrollment target is 961 participants. The study started on 2005-09. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00288106?
The interventions under investigation include: Follow-up (OTHER).
Who is sponsoring clinical trial NCT00288106?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.